12:00 AM
 | 
Mar 12, 2012
 |  BC Week In Review  |  Company News  |  Other News

QR Pharma, Michael J. Fox Foundation For Parkinson's Research neurology news

QR Pharma received a $468,000 grant from the foundation to develop Posiphen to treat Parkinson's disease. QR Pharma will conduct preclinical...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >